| The information on this web page is intended for Healthcare Professionals in the UK. It contains promotional content, prescribing information and adverse events reporting information. |
| Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited online, by telephone 0207 540 7117 or email uk.safety@tevauk.com |
The NHS's Road to Net Zero
Achieving net zero* emissions for a large organization such as the NHS is complex, but progress can be made by taking small steps along the way.
The NHS is striving to become the first national health service in the world to achieve net zero* emissions by 2045, which may involve an increase in prescribing medications with a lower carbon footprint. 01
Have you seen an increase in Salamol® (salbutamol) prescriptions?
Every time a large volume MDI (metered-dose inhaler) is used, it can result in over twice the CO2 equivalent† emissions compared to a small volume MDI because it uses more propellant, in this case, hydrofluoroalkane (HFA).02
This difference can accumulate into a significant environmental impact, given the millions of MDI inhalers used daily.03
This is the reason prescribers may be changing to Salamol®. The objective is to make a significant difference to emissions, while providing continuity of care with the same reliever medication asthma patients know and trust, salbutamol.
The carbon footprint of Salamol® CFC-Free 100 micrograms MDI has been measured and certified by The Carbon Trust as: 04
 |
12.20 kgCO2e Net Total Emissions per inhaler 0.061 kgCO2e Net Total Emissions per actuation |
Providing guidance to patients is crucial, and Teva’s local Business Managers can offer further information on Salamol® or patient support materials upon request.
Don’t forget; you can also find further information on respiratory care through Teva's Let’s Talk Respiratory programme.
For more information on The Carbon Trust, visit; www.carbontrust.com
*Net zero refers to achieving a balance between the amount of greenhouse gas produced and the amount removed from the atmosphere.
†CO2 equivalent (or KgCO2e) is the amount of CO2 which would have the equivalent global warming impact of any quantity and type of greenhouse gas (in this case HFA).
Salamol® (Salbutamol) Prescribing Information
| Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Teva UK Limited online, by telephone 0207 540 7117 or email uk.safety@tevauk.com |
References:
-
Back to contents.
NHS, Delivering a ‘Net Zero’ National Health Service. https://www.england.nhs.uk/greenernhs/wp-content/uploads/sites/51/2022/07/B1728-delivering-a-net-zero-nhs-july-2022.pdf - last accessed July 2024.
-
Back to contents.
PrescQIPP Inhaler Carbon Footprint. https://www.prescqipp.info/our-resources/bulletins/bulletin-295-inhaler-carbon-footprint/ - last accessed July 2024.
-
Back to contents.
Wilkinson, AJK., et al. BMJ Open 2019;9:e028763.
-
Back to contents.
Teva UK Limited - Data on File 346